1 report

  • ASTRAZENECA ENTERS INTO LICENSING AGREEMENT WITH SYNAIRGEN FOR SNG001
  • PARTNERSHIPS

It targets interferon alpha receptor ## and ##.

  • Asthma
  • Pharmaceutical
  • United Kingdom
  • United States
  • Synairgen plc